• Explore /
  • Poster
  • / A first-in-human phase I study of the anti-PD-1 antibody PDR001 in patients with advanced solid tumors.

A first-in-human phase I study of the anti-PD-1 antibody PDR001 in patients with advanced solid tumors.

Abstract Poster

Authors

null

Aung Naing

Department of Investigational Cancer Therapeutics (Phase 1 Program), The University of Texas MD Anderson Cancer Center, Houston, TX

Aung Naing , Hans Gelderblom , Justin F. Gainor , Patrick M. Forde , Marcus Butler , Chia-Chi Lin , Sunil Sharma , Maria Ochoa de Olza , Jan H.M. Schellens , Jean-Charles Soria , Matthew H. Taylor , Antonio P. Silva , Zhonggai Li , Sanela Bilic , Scott Cameron , Jeffrey R. Infante

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Developmental Therapeutics—Immunotherapy

Track

Developmental Therapeutics and Translational Research

Sub Track

Immune Checkpoint Inhibitors

Clinical Trial Registration Number

NCT02404441

Citation

J Clin Oncol 34, 2016 (suppl; abstr 3060)

DOI

10.1200/JCO.2016.34.15_suppl.3060

Abstract #

3060

Poster Bd #

382

Abstract Disclosures

Similar Posters

First Author: Osama E. Rahma

First Author: Jayesh Desai

First Author: Laura Quan Man Chow

First Author: Jiajian Liu